TJP1 and invasive breast carcinoma: They also indicated that both the ZO-1 protein fragment containing only PDZ domains and integral full-length ZO-1 protein could activate the β-catenin signaling pathway in invasive breast cancer cells, suggesting the functional differences of ZO-1 between normal epithelial cells and cancer cells.